Literature DB >> 15817527

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.

Julie Pildal1, An-Wen Chan, Asbjørn Hróbjartsson, Elisabeth Forfang, Douglas G Altman, Peter C Gøtzsche.   

Abstract

OBJECTIVES: To compare how allocation concealment is described in publications of randomised clinical trials and corresponding protocols, and to estimate how often trial publications with unclear allocation concealment have adequate concealment according to the protocol.
DESIGN: Cohort study of 102 sets of trial protocols and corresponding publications.
SETTING: Protocols of randomised trials approved by the scientific and ethical committees for Copenhagen and Frederiksberg, 1994 and 1995. MAIN OUTCOME MEASURES: Frequency of adequate, unclear, and inadequate allocation concealment and sequence generation in trial publications compared with protocols, and the proportion of protocols where methods were reported to be adequate but descriptions were unclear in the trial publications.
RESULTS: 96 of the 102 trials had unclear allocation concealment according to the trial publication. According to the protocols, 15 of these 96 trials had adequate allocation concealment (16%, 95% confidence interval 9% to 24%), 80 had unclear concealment (83%, 74% to 90%), and one had inadequate concealment. When retrospectively defined loose criteria for concealment were applied, 83 of the 102 trial publications had unclear concealment. According to their protocol, 33 of these 83 trials had adequate allocation concealment (40%, 29% to 51%), 49 had unclear concealment (59%, 48% to 70%), and one had inadequate concealment.
CONCLUSIONS: Most randomised clinical trials have unclear allocation concealment on the basis of the trial publication alone. Most of these trials also have unclear allocation concealment according to their protocol.

Mesh:

Year:  2005        PMID: 15817527      PMCID: PMC557221          DOI: 10.1136/bmj.38414.422650.8F

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  20 in total

Review 1.  Allocation concealment in randomised trials: defending against deciphering.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

2.  Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

Authors:  Peter Jüni; Anne W S Rutjes; Paul A Dieppe
Journal:  BMJ       Date:  2002-06-01

3.  Discrepancy between published report and actual conduct of randomized clinical trials.

Authors:  Catherine L Hill; Michael P LaValley; David T Felson
Journal:  J Clin Epidemiol       Date:  2002-08       Impact factor: 6.437

4.  The pharmaceutical industry as a political player.

Authors:  John Abraham
Journal:  Lancet       Date:  2002-11-09       Impact factor: 79.321

5.  Allocation concealment in clinical trials.

Authors:  Peter Jüni; Matthias Egger
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

6.  Allocation concealment in clinical trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group.

Authors:  Heloisa P Soares; Stephanie Daniels; Ambuj Kumar; Mike Clarke; Charles Scott; Suzanne Swann; Benjamin Djulbegovic
Journal:  BMJ       Date:  2004-01-03

Review 8.  When can a clinical trial be called 'randomized'?

Authors:  Vance W Berger; Jeffrey D Bears
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

9.  The future of institutional review boards.

Authors:  Davina Ghersi; Eric G Campbell; Rebecca Pentz; Cheryl Cox Macpherson
Journal:  Lancet Oncol       Date:  2004-05       Impact factor: 41.316

10.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

View more
  60 in total

Review 1.  The assessment of the quality of reporting of meta-analyses in diagnostic research: a systematic review.

Authors:  Brian H Willis; Muireann Quigley
Journal:  BMC Med Res Methodol       Date:  2011-12-09       Impact factor: 4.615

2.  Methodological and ethical quality of randomized controlled clinical trials in gastrointestinal surgery.

Authors:  Valérie Bridoux; Grégoire Moutel; Horace Roman; Babak Kianifard; Francis Michot; Christian Herve; Jean-Jacques Tuech
Journal:  J Gastrointest Surg       Date:  2012-07-10       Impact factor: 3.452

Review 3.  Randomized controlled trials and neuro-oncology: should alternative designs be considered?

Authors:  Alireza Mansouri; Samuel Shin; Benjamin Cooper; Archita Srivastava; Mohit Bhandari; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2015-08-22       Impact factor: 4.130

4.  Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.

Authors:  Nasim A Khan; Juan I Lombeida; Manisha Singh; Horace J Spencer; Karina D Torralba
Journal:  Arthritis Rheum       Date:  2012-07

5.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

Review 6.  The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review.

Authors:  Isabelle Jacquier; Isabelle Boutron; David Moher; Carine Roy; Philippe Ravaud
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

7.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Authors:  Lesley Wood; Matthias Egger; Lise Lotte Gluud; Kenneth F Schulz; Peter Jüni; Douglas G Altman; Christian Gluud; Richard M Martin; Anthony J G Wood; Jonathan A C Sterne
Journal:  BMJ       Date:  2008-03-03

Review 8.  Restriction of FODMAP in the management of bloating in irritable bowel syndrome.

Authors:  Wei Mon Wong
Journal:  Singapore Med J       Date:  2016-09       Impact factor: 1.858

9.  The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry.

Authors:  Changsu Han; Kyung-phil Kwak; David M Marks; Chi-Un Pae; Li-Tzy Wu; Kamal S Bhatia; Prakash S Masand; Ashwin A Patkar
Journal:  Contemp Clin Trials       Date:  2008-11-30       Impact factor: 2.226

10.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.

Authors:  Sally Hopewell; Susan Dutton; Ly-Mee Yu; An-Wen Chan; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.